Sept 29 (Reuters) - Healthcare-focused Glenview Capital

Management will meet top executives at struggling healthcare

company CVS Health ( CVS ) on Monday to propose ways it can

improve operations, The Wall Street Journal reported on Sunday.

The hedge fund's founder, Larry Robbins, has built a large

position in CVS, which amounts to about $700 million of his $2.5

billion hedge fund, the report said, citing a person familiar

with the matter.

CVS said it "maintains a regular dialogue with the

investment community as part of our robust shareholder and

analyst engagement program," and said it can't comment on

engagement with specific firms or individuals.

Glenview did not immediately respond to a Reuters'

request for comment.

Speculation has mounted among fund managers

that an activist investor may swoop in to push CVS to make

changes that would boost its share price.

Investment firm Sachem Head Capital Management

built

a new 0.2% stake in the company during the second quarter,

according to a regulatory filing in August.

Earlier in August, CVS cut its annual profit forecast to

$6.40 to $6.65 per share from its prior view of at least $7.00,

marking at least the fourth time CVS

lowered its outlook

for the year.

It also announced a multi-year plan to save $2 billion

in costs through measures such as streamlining operations and

using artificial intelligence and automation across its

business.